Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain

Molecular Pharmacology

Volumn 69, Issue 1, 2006, Pages 354-362

  Mouhat, Stéphanie ^a,b   Teodorescu, Georgeta ^c   Homerick, Daniel ^d   Visan, Violeta ^c   Wulff, Heike ^d   Wu, Yingliang ^e   Grissmer, Stephan ^c   Darbon, Hervé ^b   De Waard, Michel ^f,g,h   Sabatier, Jean Marc ^a,b  

^a Laboratoire Cellpep SA   (France)

^b CNRS   (France)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e WUHAN UNIVERSITY   (China)

^f INSERM   (France)

^g CEA GRENOBLE   (France)

^h UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; LYSINE; ORTHOCHIRUS SCROBICULOSUS TOXIN 1; POTASSIUM CHANNEL; SCORPION VENOM; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BETA SHEET; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION;

EID: 30044444119     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.017210     Document Type: Article

References (25)

1. + channel revealed by the NMR-derived structures of scorpion toxins. Neuron 15:1169-1181.
2. Beeton C, Pennington MW, Wulff H, Singh S, Nugent D, Crossley G, Khaytin I, Calabresi PA, Chen CY, Gutman GA, et al. (2005) Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. Mol Pharmacol 67:1369-1381.
3. Beeton C, Wulff H, Singh S, Botsko S, Crossley G, Gutman GA, Cahalan MD, Pennington M, and Chandy KG (2003) A novel fluorescent toxin to detect and investigate Kv1.3 channel up-regulation in chronically activated T lymphocytes. J Biol Chem 278:9928-9937.
4. Bontems F, Roumestand C, Gilquin B, Ménez A, and Toma F (1991) Refined structure of charybdotoxin: common motifs in scorpion toxins and insect defensins. Science (Wash DC) 254:1521-1523.
5. 2+-activated potassium channels. Mol Pharmacol 63:409-418.
6. + channels as targets for specific immunomodulation. Trends Pharmacol Sci 25:280-289.
7. + channels from Leiurus quinquestriatus var. hebraeus venom. Biochemistry 33:6834-6839.
8. + channels, types Kv1.1, 1.2, 1.3, 1.5 and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol 45:1227-1234.
9. Hamill OP, Marty A, Neher E, Sakmann B, and Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflueg Arch Eur J Physiol 391:85-100.
10. Jaravine VA, Nolde DE, Reibarkh MJ, Korolkova YV, Kozlov SA, Pluzhnikov KA, Grishin EV, and Arseniev AS (1997) Three-dimensional structure of toxin OSK1 from Orthochirus scrobiculosus scorpion venom. Biochemistry 36:1223-1232.
11. + channels. Toxicon 43:909-914.
12. 22, a potent Kv1.3-specific immunosuppressive polypeptide. J Biol Chem 273:32697-32707.
13. Merrifield B (1986) Solid phase synthesis. Science (Wash DC) 232:341-347.
14. 22, reveals a novel pharmacological profile. Biochemistry 42:13698-13707.
15. Mouhat S, Jouirou B, Mosbah A, De Waard M, and Sabatier JM (2004a) Diversity of folds in animal toxins acting on ion channels. Biochem J 378:717-726.
16. + channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom. Biochem J 384:1-10.
17. Possani LD, Selisko B, and Gurrola GB (1999) Animal toxins and potassium channels, in Perspectives in Drug Discovery and Design (Darbon H and Sabatier JM eds) vol 15/16, pp 15-40, Kluwer Academic Publishers, Dordrecht, The Netherlands.
18. Rauer H and Grissmer S (1996) Evidence for an internal phenylalkylamine action on the voltage-gated potassium channel Kv1.3. Mol Pharmacol 50:1625-1634.
19. Regaya I, Beeton C, Ferrat G, Andreotti N, Darbon H, De Waard M, and Sabatier JM (2004) Evidence for domain-specific recognition of SK and Kv channels by MTX and HsTx1 scorpion toxins. J Biol Chem 279:55690-55696.
20. + channels and scorpion toxins. Trends Pharmacol Sci 24:222-227.
21. +-channels. Toxicon 43:865-875.
22. + channels. Biochemistry 36:13473-13482.
23. Tytgat J, Chandy KG, Garcia ML, Gutman GA, Martin Eauclaire MF, van der Walt JJ, and Possani LD (1999) A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies. Trends Physiol Sci 20:444-447.
24. + channel expression during B cell differentiation: implications for immunomodulation and autoimmunity. J Immunol 173:776-786.
25. Yan L, Herrington J, Goldberg E, Dulski PM, Bugianesi RM, Slaughter RS, Banerjee P, Brochu RM, Briest BT, Kaczorowski GJ, et al. (2005) Stichodactyla helianthus peptide, a pharmacological tool for studying Kv3.2 channels. Mol Pharmacol 67:1513-1521.